Using an Internet Study to Improve Adherence for Psoriasis Patients

• Status: Completed
• Trial end date: 2016-04-01
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate whether participation in an Internet-based intervention helps improve short-term and long-term psoriasis treatment outcomes, in particular, adherence.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Wake Forest University
• Treatments: Fluocinonide

Criteria

Inclusion Criteria:

• Any male or female 18 years or older of age with a diagnosis of mild to moderate psoriasis by a dermatologist will be eligible for participation.

• Less than 20% of body surface involvement for psoriasis.

• Subject is capable of understanding and willing to provide a signed and dated written voluntary informed consent before any protocol specific procedures are performed.

• The subject is able to complete the study and comply with study instructions, including attending all study visits.

• In general good health with no other skin disease, disease state or physical condition which would impair evaluation of psoriasis or which would increase health risk by study participation

Exclusion Criteria:

• Individuals younger than 18 years of age.

• Known allergy or sensitivity to topical fluocinonide.

• Inability to complete all study-related visits, or inability to complete the Internet survey due to inadequate Internet access.

• Introduction of any other prescription medication, topical or systemic, for psoriasis while participating in the study. Subjects who are on systemic anti-inflammatory treatments for psoriasis must be on a stable dose for at least 3 months prior to enrollment.

• Any skin condition or disease that may require concurrent therapy or may confound evaluations

• Current enrollment in any research study involving an investigational drug